The following trials provide information to treat various types of cancer and infectious disease, both for ongoing and completed clinical trials. For more information on our oncology therapy area please click here or for our infection therapy area please click here.
- collapse An observational study of adherence to adjuvant anastrozole therapy in postmenopausal patients with early breast cancer over one year follow-up.
- collapse Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.
- collapse Epidemiological Study to Evaluate the Prevalence of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic NSCLC (Stage IIIB/IV Non-small Cell Lung Cancer)
- collapse Parameters of Acceptability, Compliance and Efficacy of Fulvestrant in Post-menopausal Patients With Advance Breast Cancer (FRAME)
- collapse A Phase I, Open-label, Dose-escalation Study to Assess the Safety and Tolerability of AZD0530 in Patients with Advanced Solid Malignancies
- collapse Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer (BC) (FIONA)
- collapse Observations in patients with a long term response on gefitinib (Iressa) in the Expanded Access Program.
- collapse A randomized, double-blind phase II trial to assess the efficacy and safety of bicalutamide (Casodex ) associated to ZD6474 (Zactima ) or to placebo in patients with castration-refractory metastatic prostate cancer without any clinical symptom related to disease progression.
- collapse An Epidemiological Study on Antimicrobial Treatment of Nosocomial Infections in Clinical Practice
- collapse A Multi-centre, Single-blind, Randomised, Parallel Group, Phase IIb Dose Rate Range Finding Study to Find Maintenance Dose Rate Range of ICI35,868 for the Minimal-to-moderate Sedation on Gastrointestinal Endoscopic Tests (Including Endoscopic Polypectomy)
